Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Flyvbjerg

Showing results (141-150 of 284) with videos related to

Pageof 29
Sort By:
Diabetes Care|April 25, 2009
Adiponectin and lipoprotein particle sizeRam Weiss, James D Otvos, Allan Flyvbjerg, et al.
Atherosclerosis|March 29, 2008
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic miceSusanne Bro, Allan Flyvbjerg, Christoph J Binder, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2014
Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosisSøren Lindberg, Jan S Jensen, Rasmus Mogelvang, et al.
Endocrinology|August 23, 2003
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life spanKaren T Coschigano, Amy N Holland, Markus E Riders, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2008
Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patientsGowsini Joseph, Lise Tarnow, Anne Sofie Astrup, et al.
Hepatology (Baltimore, Md.)|February 16, 2012
Fatty liver index, gamma-glutamyltransferase, and early carotid plaquesMichaela Kozakova, Carlo Palombo, Marco Paterni Eng, et al.
Scandinavian Cardiovascular Journal : SCJ|June 8, 2010
Complement activation, endothelial dysfunction, insulin resistance and chronic heart failureMette Bjerre, Caroline Kistorp, Troels Krarup Hansen, et al.
Nephron. Experimental Nephrology|June 1, 2005
Pathophysiological role of vascular endothelial growth factor in the remnant kidneyBieke F Schrijvers, Allan Flyvbjerg, Ronald G Tilton, et al.
European Journal of Endocrinology|July 27, 2006
Glycosaminoglycans increase levels of free and bioactive IGF-I in vitroAnne Vestergård Møller, Søren Peter Jørgensen, Jian-Wen Chen, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective studyHeidi Marie Christensen, Caroline Kistorp, Morten Schou, et al.
Pageof 29

Showing results (141-150 of 284) with videos related to

Sort By:
Pageof 29
Diabetes Care|April 25, 2009
Adiponectin and lipoprotein particle sizeRam Weiss, James D Otvos, Allan Flyvbjerg, et al.
Atherosclerosis|March 29, 2008
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic miceSusanne Bro, Allan Flyvbjerg, Christoph J Binder, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2014
Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosisSøren Lindberg, Jan S Jensen, Rasmus Mogelvang, et al.
Endocrinology|August 23, 2003
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life spanKaren T Coschigano, Amy N Holland, Markus E Riders, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2008
Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patientsGowsini Joseph, Lise Tarnow, Anne Sofie Astrup, et al.
Hepatology (Baltimore, Md.)|February 16, 2012
Fatty liver index, gamma-glutamyltransferase, and early carotid plaquesMichaela Kozakova, Carlo Palombo, Marco Paterni Eng, et al.
Scandinavian Cardiovascular Journal : SCJ|June 8, 2010
Complement activation, endothelial dysfunction, insulin resistance and chronic heart failureMette Bjerre, Caroline Kistorp, Troels Krarup Hansen, et al.
Nephron. Experimental Nephrology|June 1, 2005
Pathophysiological role of vascular endothelial growth factor in the remnant kidneyBieke F Schrijvers, Allan Flyvbjerg, Ronald G Tilton, et al.
European Journal of Endocrinology|July 27, 2006
Glycosaminoglycans increase levels of free and bioactive IGF-I in vitroAnne Vestergård Møller, Søren Peter Jørgensen, Jian-Wen Chen, et al.
Metabolism: Clinical and Experimental|October 22, 2013
Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective studyHeidi Marie Christensen, Caroline Kistorp, Morten Schou, et al.
Pageof 29